Company intelligence / Profile preview
OrthoLogic Corp.
Tempe, Arizona, USAbiospace.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
OrthoLogic developed both marketed medical devices for bone growth stimulation and a pipeline of synthetic therapeutic peptides targeting tissue repair and fibrosis. Its lead peptide candidate Chrysalin® showed positive results in Phase I/II studies for fracture healing and was cleared for Phase III trials by the FDA around the mid-late 2000s. The company also advanced AZX100 into preclinical development for fibrotic diseases but did not reach commercialization before rebranding as Capstone Therapeutics in late September, 2008.[4][5][9]
- Therapeutic areas
- OtherPulmonologyEndocrinologyCardiovascular
- Modalities
- Synthetic peptidesMedical devices (bone growth stimulators)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Quintiles Transnational Corp. alliance to develop Chrysalin® [4]; no other major pharma partnerships noted.
Beyond the preview
Go deeper on OrthoLogic Corp..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OrthoLogic Corp..